Coronavirus Vaccine Approval Will Launch Unprecedented Public Health Initiative
When one or more coronavirus vaccines receives FDA emergency use authorization, it will launch a public health and logistics initiative unlike any in U.S. history. Hundreds of millions of doses will have to distributed nationwide and kept cold until healthcare professionals can administer not one, but two doses to each person. And enough skeptical members of the population will have to be persuaded to receive the vaccine to slow virus transmission.
“Time is of the essence because the virus is already so widespread,” said Pinar Keskinocak, the William W. George Chair and professor in the H. Milton Stewart School of Industrial and Systems Engineering and director of the Center for Health and Humanitarian Systems at the Georgia Institute of Technology.
Spotlight
Half of Earth’s satellites restrict use of climate data
Mariel Borowitz
The Atlanta Journal-Constitution —
Women's Health Magazine —
The Atlanta Journal-Constitution —
Optimistdaily —
University Business Magazine —
Scientific American —
True Merrill is a senior research scientist at the Georgia Tech Research Institute. He is a member of the team that developed and implemented Georgia Tech's Covid-19 surveillance testing program. (audio slideshow by Allison Carter)
Cristina Fannin, a construction manager in Georgia Tech Facilities Management, talks about her work.
